Research Tools & Protocols

Dosage Reference Table

For Research Use Only. Not for Human or Veterinary Use.

Overview

A master reference of the dosing parameters reported in the research literature for every compound in this database — dose range, route, frequency, cycle length, half-life, solvent and storage — grouped by category. These are reconstitution-oriented reference figures for laboratory research only, not dosing guidance for human or veterinary use.

How to Read This Table

Each category below lists its compounds side by side. Figures are typical research values from the literature; always cross-check the individual compound page and its Certificate of Analysis.

GLP-1 Receptor Agonists

PropertyTirzepatideRetatrutideSemaglutide
Research dose0.25–2 mg/wk0.25–1.2 mg/wk0.25–2.4 mg/wk
RouteSCSCSC / oral
FrequencyWeeklyWeeklyWeekly (SC)
Cycle12–104 wk (clinical)12–104 wk (clinical)12–104 wk (clinical)
Half-life~ 5 days~ 6 days~ 7 days
SolventBacteriostatic waterBacteriostatic waterBacteriostatic water
StoragePowder −20°C; recon 2–8°C 14 dPowder −20°C; recon 2–8°C 14 dPowder −20°C; recon 2–8°C 14 d

Cosmetic & Topical Peptides

PropertyGHK-CuMatrixylArgirelineMatrixyl 3000SNAP-8
Research dose0.1–3% (topical)0.5–5% (topical)1–10% (topical)1–8% (topical)1–10% (topical)
RouteTopicalTopicalTopicalTopicalTopical
Frequency1–2×/day1–2×/day1–2×/day1–2×/day1–2×/day
CycleOngoing (topical)Ongoing (topical)Ongoing (topical)Ongoing (topical)Ongoing (topical)
Half-life~ 15 min (GHK)————
SolventFormulation baseEmulsion / co-solventWater / formulation baseEmulsion / co-solventWater / formulation base
StoragePowder −20°C; solution 2–8°CPowder −20°C; emulsion 12+ moPowder −20°C; solution 2–8°CPowder −20°C; emulsion 12+ moPowder −20°C; solution 2–8°C

Tissue Repair & Regenerative

PropertyBPC-157TB-500 (Ac-SDKP)
Research dose10–50 µg/kg1–5 mg
RouteSC / oralSC / IM
Frequency1–2×/day1–2×/wk
Cycle2–8 wk4–8 wk
Half-life~ 15 min~ 2–6 h
SolventBacteriostatic waterBacteriostatic water
StoragePowder −20°C; recon 2–8°C 7 dPowder −20°C; recon 2–8°C 7 d

Mitochondrial & Metabolic

PropertyMOTS-cSS-31 (Elamipretide)HumaninAOD-9604
Research dose5–15 mg0.5–2 mg2–8 mg300–1000 µg
RouteSC / IPSC / IVSC / IVSC
Frequency1–2×/wkDaily1–2×/dayDaily
Cycle4–12 wk2–8 wk4–12 wk4–12 wk
Half-life~ 2–4 h~ 2–4 h~ 1–3 h~ 2–4 h
SolventBacteriostatic waterBacteriostatic waterBacteriostatic waterBacteriostatic water
StoragePowder −20°C; recon 2–8°C 7 dPowder −20°C; recon 2–8°C 7 dPowder −20°C; recon 2–8°C 7 dPowder −20°C; recon 2–8°C 7 d

Growth Factors & Signaling

PropertyMK-677 (Ibutamoren)IpamorelinGHRP-2GHRP-6CJC-1295Sermorelin
Research dose10–25 mg200–500 µg100–300 µg100–300 µg1–2 mg200–500 µg
RouteOralSCSCSCSCSC / IV
FrequencyDaily2–3×/day2–3×/day2–3×/dayEvery 5–8 dDaily
Cycle12–52 wk8–16 wk8–16 wk8–16 wk8–16 wk12–24 wk
Half-life~ 24 h~ 2 h~ 30 min~ 30 min~ 6–8 days~ 12 min
SolventN/A (oral)Bacteriostatic waterBacteriostatic waterBacteriostatic waterBacteriostatic waterBacteriostatic water
StorageSolid 2–8°C, dry, darkPowder −20°C; recon 2–8°CPowder −20°C; recon 2–8°CPowder −20°C; recon 2–8°CPowder −20°C; recon 2–8°CPowder −20°C; recon 2–8°C

Cognitive & Neuro Regulation

PropertySemaxSelankNoopeptCerebrolysin
Research dose200–600 µg200–600 µg10–20 mg5–20 mL
RouteIntranasalIntranasalOral / SLIV / IM
Frequency1–2×/day1–2×/day2–3×/day3–7×/wk
Cycle1–3 mo1–3 mo1–3 mo4–12 wk
Half-life~ 30 min~ 20 min~ 2–5 h~ 4–6 h
SolventBacteriostatic waterBacteriostatic waterWater / salinePre-mixed
StoragePowder −20°C; recon 2–8°C 7 dPowder −20°C; recon 2–8°C 7 dSolid 2–8°C, dry, dark15–25°C, sealed, dark

Sleep & Pineal Peptides

PropertyEpitalonPinealon
Research dose5–10 mg5–10 mg
RouteSCSC
FrequencyDaily (5–10 d)Daily (5–10 d)
Cycle2–4×/yr2–4×/yr
Half-life~ 30–60 min~ 20–40 min
SolventBacteriostatic waterBacteriostatic water
StoragePowder −20°C; recon 2–8°C 7 dPowder −20°C; recon 2–8°C 7 d

Dosing Units & Syringe Conversion

1 mg = 1000 µg. Volume to withdraw (mL) = dose ÷ concentration. On a 1 mL (100-unit) insulin syringe, 0.1 mL = 10 units.

Concentration250 µg dose =500 µg dose =1 mg dose =
2.5 mg/mL0.10 mL (10 u)0.20 mL (20 u)0.40 mL (40 u)
5 mg/mL0.05 mL (5 u)0.10 mL (10 u)0.20 mL (20 u)

Important Notes

  • These are research reference ranges, not recommendations for human or veterinary use.
  • Cosmetic peptides are expressed as topical formulation percentages, not injected doses.
  • MK-677 and Noopept are oral; Cerebrolysin is a pre-mixed solution dosed by volume.

For laboratory research use only. Not for human or veterinary use, diagnosis, or therapeutic application. Descriptions refer to published research contexts and are not medical or product claims.

Need research-grade peptides?

HPLC-verified, COA per batch. Tell us the quantity you need.

Request a Quote